<![CDATA[Contributor: American Patients vs Foreign Governments—A Tale of 2 Value Sets]]>
Patients in the US currently benefit from faster access1 to more innovations2 compared with their ex-US peers. American patients consistently report valuing access to pharmaceuticals and the autonomy to choose, alongside their providers, from available …